# SELLAS Life Sciences Group Begins $150 Million Stock Offering

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/59854
Published: 2026-11-17T21:16:59.000Z
Updated: 2026-11-17T21:16:59.000Z
Section: Business

> The company plans to grant underwriters a 30-day option to buy additional shares.

SELLAS Life Sciences Group, Inc. (SLS) began an underwritten $150 million public offering of common stock Tuesday, Nov. 17, and plans to grant underwriters a 30-day option to purchase additional shares.

The offering follows positive results from REGAL, the company’s Phase 3 trial involving patients with acute myeloid leukemia. SLS shares [rose more than 281% after the trial results](<https://www.tokenpost.com/news/investing/59468>). The trial showed a statistically significant improvement in overall survival.



## Links in this article

- [rose more than 281% after the trial results](https://www.tokenpost.com/news/investing/59468)
